Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Angel Oak Financial Strategies Income Term Trust Announces Rights Offering and Monthly Distribution
-
Savara Announces New Employment Inducement Grant
-
Columbia Sportswear Company to Announce First Quarter 2025 Financial Results on Thursday, May 1, 2025
-
Fubo Announces Inducement Grants Under NYSE Listing Rule 303A.08
-
Aon Announces First Quarter 2025 Earnings Release and Conference Call
-
Virtus Investment Partners to Announce First Quarter 2025 Results on Friday, April 25
-
The Beachbody Company, Inc. Receives Notice from the NYSE
-
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
-
Tianci International, Inc. Announces Closing of $7 Million Public Offering
-
Dynagas LNG Partners LP Announces Filing of Form 20-F With the SEC
-
4DMT Announces New Employment Inducement Grants
-
Aether Holdings Announces Closing of Initial Public Offering
-
Top Technology Executives Recognized at the 2025 SeattleCIO ORBIE Awards
-
Graphano Announces Second Extension of Warrant Expiry Date
-
Bakkt INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bakkt Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MGPI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MGP Ingredients, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
EU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TFII INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TFI International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FLNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fluence Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
APP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Workiva: What Businesses Need to Know About CSRD Omnibus Proposals
-
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
NioCorp Provides Preliminary Financial Results for the Three and Nine Month Periods Ended March 31, 2025
-
MULN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Mullen Automotive, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
EIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edison International Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
U.S. Healthcare Seeks New Partners to Counter China Tariff Turmoil, Black Book Survey Reveals
-
Hingham Savings Reports First Quarter 2025 Results
-
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
WORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
argenx Announces Annual General Meeting of Shareholders on May 27, 2025
-
Russell Investments Canada Limited Announces Monthly Distributions for Exchange Traded Fund Series
-
iOThree Limited Announces Closing of Initial Public Offering
-
Antanas Guoga Announces Filing of Early Warning Report Related to Sol Strategies Inc.
-
OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
-
UN Global Compact and private sector move to accelerate progress on SDGs in Africa
-
CountWize Unveils Cutting-Edge Solution for Recovering Stolen Cryptocurrencies.
-
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
-
Dr. Sudipta Mohanty Scholarship for Underserved Communities in Medicine Announce Scholarship Winner
-
Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns
-
Marti Law Group Files Amicus Brief on Behalf of NP2Go in Federal Suit Challenging FDA’s Removal of Semaglutide From Drug Shortage List
-
OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
-
SHAREHOLDER DEADLINE: AppLovin (APP) Investors Are Reminded of Deadline in Securities Action
-
PU Prime And Argentine Football Association Unite to Elevate Skills On and Off the Field
-
Binge Networks Goes Live: Revolutionizing Streaming with Exclusive Weekly Live Events
-
PU Prime Wins Best Customer Service Award at ADVFN Awards
